Highmark sues UPMC over billing for cancer drugs

Published September 4, 2014 7:08pm ET



PITTSBURGH (AP) — Health insurer Highmark Inc. has sued the University of Pittsburgh Medical Center claiming the hospital network has overbilled it by $300 million for cancer drugs since 2010.

Highmark’s lawsuit, filed late Wednesday, contends UPMC has been charging for chemotherapy treatments administered at doctor’s offices as though they were performed at hospital outpatient clinics. Hospital outpatient clinics charge more for the same treatments.

Already a print subscriber? Click here to login/register your account

Trusted reporting.Unlimited access.

Subscribe for full access to Washington Examiner coverage, expert political analysis, and subscriber-only journalism.

Get Unlimited Access

Already a member? Log in

Cancel anytime.